Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × CRC × HLX07 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 1 Squamous NSCLC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Neoplasm Metastasis 1 Colonic Neoplasms 1 CRC 1

Interventions

Cetuximab 2 camrelizumab 1 Oxaliplatin 1 Leucovorin 1 KD025 1 Irinotecan 1 HLX07 1 Folfox protocol 1 Fluorouracil 1 CCT239065 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05239650 2022-05-03

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

Shanghai Henlius Biotech

Phase 2 Not yet recruiting

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡